Back
Novavax, Inc. 10K Form
Sell
25
NVAX
Novavax, Inc.
NVAX
Novavax, Inc.
Novavax, Inc.
Last Price:
$8.43
Seasonality Move:
27.94%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-10 | 10Q | NVAX/Novavax, Inc. Quarterly |
| 2024-02-28 | 10K | NVAX/Novavax, Inc. Annual |
| 2023-11-09 | 10Q | NVAX/Novavax, Inc. Quarterly |
| 2023-08-08 | 10Q | NVAX/Novavax, Inc. Quarterly |
| 2023-05-09 | 10Q | NVAX/Novavax, Inc. Quarterly |
| 2023-02-28 | 10K | NVAX/Novavax, Inc. Annual |
Receive NVAX News And Ratings
See the #1 stock for the next 7 days that we like better than NVAX
NVAX Financial Statistics
Sales & Book Value
| Annual Sales: | $1.1B |
|---|---|
| Cash Flow: | $-41.7M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.79 |
| Price / Book: | 32.13 |
Profitability
| EPS (TTM): | 2.38050 |
|---|---|
| Net Income (TTM): | $440.3M |
| Gross Margin: | $1.1B |
| Return on Equity: | 0% |
| Return on Assets: | 33.38% |
Novavax, Inc. Earnings Forecast
Key Novavax, Inc. Financial Ratios
-
The Gross Profit Margin over the past 31 years for NVAX is 93.67%.
-
The Selling, General & Administrative Expenses for NVAX have been equal to 14.02% of Gross Profit Margin.
-
The Research & Development expenses have been 29.98% of Revenue.
-
The Interest Expense is 5.12% of Operating Income.
-
The Net Earning history of NVAX is 39.19% of Total Revenues.
-
Per Share Earnings over the last 31 years have been positive in 15 years.
Novavax, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | NVAX |
| CUSIP: | 670002 |
| Website: | novavax.com |
Debt
| Debt-to-Equity Ratio: | -2.18 |
|---|---|
| Current Ratio: | 2.13 |
| Quick Ratio: | 1.87 |
Price-to-Earnings
| Trailing P/E Ratio: | 3.15 |
|---|---|
| Forward P/E Ratio: | 75.38 |
NVAX Technical Analysis vs Fundamental Analysis
Sell
25
Novavax, Inc. (NVAX)
is a Sell
Is Novavax, Inc. a Buy or a Sell?
-
Novavax, Inc. stock is rated a SellThe current Novavax, Inc. [NVAX] share price is $7.98. The Score for NVAX is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.